Patients’ and Healthcare Professionals’ Experiences of Idiopathic Pulmonary Fibrosis Treatment with the Pirfenidone 801 mg Tablet Formulation: A Multinational Survey

INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a progressive, debilitating interstitial lung disease. Two antifibrotics, pirfenidone and nintedanib, are available for IPF treatment. Pirfenidone is available as 267 mg capsules and, more recently, as 267 mg and 801 mg tablets. The aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Lancaster, Lisa H., Valenzuela, Claudia, Mason, Wendi, Neurohr, Claus, Ripamonti, Elena, Kirchgaessler, Klaus-Uwe, Cottin, Vincent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229113/
https://www.ncbi.nlm.nih.gov/pubmed/32193713
http://dx.doi.org/10.1007/s41030-020-00111-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229113/
https://www.ncbi.nlm.nih.gov/pubmed/32193713
http://dx.doi.org/10.1007/s41030-020-00111-y

Ejemplares similares